enGene Therapeutics Inc. (ENGN) stock
ENGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends October 31Also trades as ENGNW
$1.72−0.17 (-8.99%)
Close on Nov 17, 2026Market cap $115.27MP/E –Yield 0.00%
enGene Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
enGene Therapeutics's market cap was $120.63M on Nov 11, 2026, against $412.42M a year earlier. Over the last 4 years it ranged from $5.10M to $525.91M, with a median of $211.05M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $120.63M | -74.3% |
| 2025 | Dec 31, 2025 | $469.73M | +38.6% |
| 2024 | Dec 31, 2024 | $338.99M | +58.3% |
| 2023 | Dec 29, 2023 | $214.12M | +3013.4% |
| 2022 | Dec 30, 2022 | $6.88M | – |
See a number that looks wrong?